MCL1 and acute myeloid leukemia: Furthermore, a study by Carter et al. demonstrated that the inhibition of MCL-1 sensitizes AML cells and AML stem/progenitor cells to BCL-2 inhibition, including those with intrinsic and acquired resistance to venetoclax.